Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors

Autor: van Eggermond, Anna M, Schaapveld, Michael, Janus, Cécile Pm, de Boer, Jan Paul, Krol, Augustinus Dg, Zijlstra, Josée M, van der Maazen, Richard Wm, Kremer, Leontien C, van Leerdam, Monique E, Louwman, Marieke Wj, Visser, Otto, De Bruin, Marie L, Aleman, Berthe Mp, van Leeuwen, Flora E, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: British Journal of Cancer
British Journal of Cancer, 117, 3, pp. 306-314
Van Eggermond, A M, Schaapveld, M, Janus, C P M, De Boer, J P, Krol, A D, Zijlstra, J M, Van Der Maazen, R W M, Kremer, L C, Van Leerdam, M E, Louwman, M W J, Visser, O, De Bruin, M L, Aleman, B M P & Van Leeuwen, F E 2017, ' Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors ', British Journal of Cancer, vol. 117, no. 3, pp. 306-314 . https://doi.org/10.1038/bjc.2017.177
British Journal of Cancer, 117(3), 306-314. Nature Publishing Group
British journal of cancer, 117(3), 306-314. Nature Publishing Group
British Journal of Cancer, 117(3), 306-314
British Journal of Cancer, 117(3), 306. Nature Publishing Group
van Eggermond, A M, Schaapveld, M, Janus, C P, de Boer, J P, Krol, A D, Zijlstra, J M, van der Maazen, R W, Kremer, L C, van Leerdam, M E, Louwman, M W, Visser, O, De Bruin, M L, Aleman, B M & van Leeuwen, F E 2017, ' Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors ', B J C, vol. 117, no. 3, pp. 306-314 . https://doi.org/10.1038/bjc.2017.177
British Journal of Cancer, 117, 306-314

Contains fulltext : 177780.pdf (Publisher’s version ) (Open Access) BACKGROUND: Hodgkin lymphoma (HL) survivors are at increased risk of second malignancies, but few studies have assessed colorectal cancer (CRC) risk after HL treatment. We assessed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7595fd6daf279e7e1e99120d7057f813
https://hdl.handle.net/1887/115418

Comparing causes of death of Hodgkin lymphoma and breast cancer patients between medical records and cause-of-death statistics.

Autor: de Vries S; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands, f.v.leeuwen@nki.nl., Schaapveld M; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands, f.v.leeuwen@nki.nl., Kardaun JW; Department of Health and Care, Statistics Netherlands, The Hague, the Netherlands.; Department of Public Health, Academic Medical Center, Amsterdam, the Netherlands., de Bruin KH; Department of Health and Care, Statistics Netherlands, The Hague, the Netherlands., Krol AD; Department of Radiotherapy, Leiden University Medical Center, Leiden, the Netherlands., Lugtenburg PJ; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Jacobse JN; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands, f.v.leeuwen@nki.nl., Aleman BM; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Leeuwen FE; Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands, f.v.leeuwen@nki.nl.

Publikováno v: Clinical epidemiology [Clin Epidemiol] 2018 Oct 16; Vol. 10, pp. 1523-1531. Date of Electronic Publication: 2018 Oct 16 (Print Publication: 2018).